Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).
Celastrol and Its Role in Controlling Chronic Diseases.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Cytosolic phospholipase A2 plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway.
Reduced Sterol Regulatory Element-Binding Protein (SREBP) Processing Through Site-1 Protease (S1P) inhibition Alters Oligodendrocyte Differentiation in vitro.
Catalpol induces oligodendrocyte precursor cell-mediated remyelination in vitro.
Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment.
Genetics of rat neuroinflammation.
Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice.
[Acute kidney injury (AKI) requireing renal replacement therapy in a patient treated with intravenous immunoglobulin].
Health Care Resource Utilization Associated with Pediatric Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
Gene expression profiling in multiple sclerosis brain.
Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis.
Clinical Overlap of Multiple Sclerosis and Autoimmune Hepatitis: Three Cases.
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot study.
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits.
Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis.
Chemical exchange saturation transfer of the cervical spinal cord at 7 T.
The spectrum of leukodystrophies in children: Experience at a tertiary care centre from North India.
Accelerated longitudinal gray/white matter contrast decline in aging in lightly myelinated cortical regions.
Corpus callosum thickness in children: an MR pattern-recognition approach on the midsagittal image.
Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial.
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta.
Pemetrexed-Induced Nephrogenic Diabetes Insipidus.
Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.
Pages
« first
‹ previous
…
687
688
689
690
691
692
693
694
695
…
next ›
last »